G&E (4911.TWO) monthly revenue, September 2026

G&E reported revenue of NT$0.01bn for September 2026, down 1.1% from the previous month and down 56.0% from a year earlier. Year-to-date revenue was NT$0.10bn, down 57.9% year on year. It ranked 146 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.

中文版

MonthRevenue NT$bnMoM %YoY %
September 20260.01-1.1-56.0